The designation builds on the unit’s role as the first G4X Early Access Program site and supports broader global adoption of G4X. San Diego, CA and Boston, MA — Singular Genomics today announced that the Spatial Technologies Unit (STU) at Beth Israel Deaconess Medical Center (BIDMC), a Dana-Farber/Harvard Cancer Center (DF/HCC) Core Facility, has been designated a G4X™ Center of Excellence. The STU [...]

New platform eliminates hydrodynamic shear stress and scales isometrically from 50 mL to 250 mL, targeting a reduction in CAPEX and media costs. SAN FRANCISCO -- Stämm launched the High-Throughput Bioprocessor (HTB), an automated, single-use biomanufacturing platform for adherent and suspension cells. The HTB is engineered to eliminate the infrastructure constraints that slow research and development, and [...]

Laboratories running wastewater surveillance, bloodstream pathogen detection, or urine-based STI screening no longer need to choose between sample volume and automation. SwiftXtractor™ SL processes up to 40 mL in a single run, replacing manual concentration steps that cost time, introduce variability, and limit throughput. Compact, portable, and ready for your bench.   Hallbergmoos, Germany — [...]

Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision BOULDER, CO – Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology, giving researchers scalable access to high purity 100-400nt RNA constructs for next-generation therapeutics. The agreement brings to market an approach developed [...]

Siemens brings world-class capabilities in industrial AI, digital twin technology, and engineering to DOE’s Genesis Mission, building on its longstanding collaboration Today, Siemens announced it has signed a Memorandum of Understanding (MOU) with the U.S. Department of Energy (DOE) to support the Genesis Mission, a federal initiative to modernize America’s scientific infrastructure and strengthen the [...]

W. L. Gore & Associates (Gore) is collaborating with customized ligand partners to introduce a new range of high-performance affinity membrane chromatography products. This initiative expands Gore’s presence in the bioprocessing industry beyond Protein A-based solutions, further advancing purification performance and scalability for biopharmaceutical manufacturers. NEWARK, Del. -- W. L. Gore & Associates, Inc. ("Gore"), [...]

Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. - Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in [...]

Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of Designer Drugs, the essential GC‑MS spectral database used by forensic laboratories worldwide for the rapid identification of illicit substances. As the landscape of novel psychoactive substances (NPS) continues [...]

Introduction As laboratory purification requirements continue to evolve, the demand for higher efficiency, precision, and environmental sustainability has become paramount. Building upon the robust foundation of its predecessor, Welch Materials is proud to announce the official release of the WelPrep 2000 G2 Preparative High-Performance Liquid Chromatography System. This second-generation system is the result of deep technical refinement and [...]

Purpose-built enterprise SaaS solution streamlines bioprocess workflows and accelerates digital transformation for global biopharmaceutical development Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations. [...]